Molina Healthcare, Inc. (MOH) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2024)
MOH's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
MOH Revenue Analysis (2014–2025)
As of February 28, 2026, Molina Healthcare, Inc. (MOH) generated trailing twelve-month (TTM) revenue of $45.43 billion, reflecting solid growth of +8.3% year-over-year. The most recent quarter (Q4 2025) recorded $11.38 billion in revenue, down 0.9% sequentially.
Looking at the longer-term picture, MOH's 5-year compound annual growth rate (CAGR) stands at +18.5%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $45.43 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows MOH's business is primarily driven by Medicaid Solutions Segment (79%), Medicare (14%), and Marketplace (6%). With over half of revenue concentrated in Medicaid Solutions Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CNC (+19.4% YoY), MOH has underperformed the peer group in terms of revenue growth. Compare MOH vs CNC →
Peer Comparison
Compare MOH's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MOHCurrent | $45.4B | +8.3% | +18.5% | 1.7% | |
| CNC | $194.8B | +19.4% | +11.9% | -3.9% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $45.43B | +11.7% | $0 | - | $781.0M | 1.7% |
| 2024 | $40.65B | +19.3% | $4.74B | 11.7% | $1.71B | 4.2% |
| 2023 | $34.07B | +6.6% | $4.33B | 12.7% | $1.57B | 4.6% |
| 2022 | $31.97B | +15.1% | $3.93B | 12.3% | $1.17B | 3.7% |
| 2021 | $27.77B | +43.0% | $3.28B | 11.8% | $1.02B | 3.7% |
| 2020 | $19.42B | +15.4% | $2.68B | 13.8% | $1.08B | 5.6% |
| 2019 | $16.83B | -10.9% | $2.44B | 14.5% | $1.04B | 6.2% |
| 2018 | $18.89B | -5.0% | $2.62B | 13.9% | $1.13B | 6.0% |
| 2017 | $19.88B | +12.3% | $1.88B | 9.5% | $-555,000,000 | -2.8% |
| 2016 | $17.71B | +25.9% | $1.77B | 10.0% | $306.0M | 1.7% |
See MOH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MOH Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare MOH vs AGIO
See how MOH stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is MOH's revenue growth accelerating or slowing?
MOH maintains +8.3% revenue growth, in line with its 5-year CAGR of +18.5%. TTM revenue stands at $45.4B. Growth rate remains consistent with historical average.
What is MOH's long-term revenue growth rate?
Molina Healthcare, Inc.'s 5-year revenue CAGR of +18.5% reflects the sustained expansion pattern. Current YoY growth of +8.3% is near this long-term average.
How is MOH's revenue distributed by segment?
MOH reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.